Dandekar Atul sold MAZE
February 27, 2026 · Form 4 insider transaction
Dandekar Atul sold 3,761 shares of Maze Therapeutics, Inc. at $45.72 per share, a transaction worth $172.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,761
Price
$45.72
Total value
$172.0K
InsiderDandekar Atul
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after10,503
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.55 to $46.02 per share, inclusive.